COMMUNIQUÉS West-GlobeNewswire

Rose Hill Life Sciences Appoints Bryan Smith as Scientific Advisor
29/07/2026
Veteran Drug Discovery Executive Brings Nearly Two Decades of Oncology and Translational Research Leadership to Advance Rose Hill’s Clinical Pipeline BOSTON, July 29, 2026 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences (“ [...]
Realize Medical Appoints Chris Marrus to Board of Directors
29/07/2026
Surgical robotics and medtech commercialization veteran joins Realize Medical's board as the company scales Elucis, its FDA-cleared VR surgical planning platform OTTAWA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- [...]
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
29/07/2026
First wave of five directly operated clinics across Indonesia’s five major metropolitan areas with an initial investment of approximately US$1 million; standardized, machine-led clinic format designed for disciplined, [...]
PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules
29/07/2026
New modules, developed with Harley Academy, extend the PACE Training & Education Portal across foundational and advanced clinical techniques RICHMOND HILL, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM® , a [...]
Walmart Canada, Associates and Customers Raise $7.2 Million to Support Children’s Hospitals Across Canada
29/07/2026
MISSISSAUGA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- Walmart Canada, associates and customers came together once again this spring, raising $7.2 million to support children’s hospital foundations across the country. [...]
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
29/07/2026
MOUNTAIN VIEW, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
29/07/2026
Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
29/07/2026
WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) today announced that it has entered into a definitive agreement [...]
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
29/07/2026
NEEDHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
Angelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family
29/07/2026
Citizen Health's AI advocate for rare disease families debuts for the Angelman community at the 2026 ASF Family Conference SAN FRANCISCO and DENVER, July 29, 2026 (GLOBE NEWSWIRE) -- The Angelman Syndrome Foundation ( [...]
Tasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155)
29/07/2026
TSRF-786C demonstrates sub-nanomolar affinity, a favorable in vitro safety and immunogenicity profile, and broad potential across ADCs, bispecifics, and cell therapies NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Tasrif [...]
Fortrea Reports Second Quarter 2026 Results
29/07/2026
Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: Revenues of $678.2 million Book-to-bill [...]
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
29/07/2026
FDA submission seeks to bring KHINDIVI to larger pediatric patient population within the adrenal insufficiency market New formulation successfully demonstrated bioequivalence to ALKINDI SPRINKLE ® Submission allows for [...]
Shape Therapeutics Receives Research Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance SHP-201, a One-Time Gene Therapy to Treat Parkinson’s Disease
29/07/2026
Grant supports IND-enabling studies of an intravenously delivered, disease-modifying gene therapy designed to reduce alpha-synuclein in the brain regions most affected by Parkinson’s disease SEATTLE, July 29, 2026 ( [...]
Atavistik Bio Appoints Habib Dable to its Board of Directors
29/07/2026
Mr. Dable brings deep expertise in clinical development, commercialization, and corporate strategy to support Atavistik Bio’s next phase of growth CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Atavistik Bio, a [...]
Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy
29/07/2026
Q2 2026 revenues of $4.1 billion decreased by 1% in U.S. dollars year-over-year (YoY) and by 3% in local currency (LC) terms, mainly due to lower generics revenues. Our key innovative brands collectively grew 43% YoY in [...]
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
29/07/2026
Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward Standard of Care SUNNYVALE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- CeriBell [...]
Anika Reports Second Quarter 2026 Financial Results
29/07/2026
Commercial Channel Revenue Increased 17% to a Record $13.9 Million Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020 Raising Full-Year 2026 Financial [...]
Integra LifeSciences Reports Second Quarter 2026 Financial Results
29/07/2026
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending [...]

Pages